MELBOURNE: Pathkey.AI Ltd has entered into a binding agreement to acquire Singapore-based Chipforge Pte Ltd, an AI-driven semiconductor design platform, as the Australian technology company moves to extend its artificial intelligence capabilities beyond clinical trial optimisation into chip engineering. The all-scrip transaction, announced Wednesday, would give Pathkey an irrevocable option to buy 100% of…